• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/21/24 1:36:28 PM ET
    $AGRI
    $AKAN
    $ALLO
    $AONC
    Metal Fabrications
    Industrials
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AGRI alert in real time by email

    Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.

    James Hardie Industries posted adjusted earnings of 40 cents per share, missing market expectations of 42 cents per share. The company's quarterly sales came in at $1.005 billion versus estimates of $1.009 billion, according to data from Benzinga Pro.

    JP Morgan analyst Al Harvey downgraded James Hardie Industries from Overweight to Neutral.

    James Hardie Industries shares dipped 14.3% to $31.36 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • MGO Global, Inc. (NASDAQ:MGOL) shares jumped 194% to $0.6739 after the company posted first-quarter results.
    • Mangoceuticals, Inc. (NASDAQ:MGRX) gained 121% to $0.5598 after the company announced the development of oral formulations of Semaglutide and Tirzepatide.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) jumped 87% to $2.3750 after the company presented Phase 2 clinical trial results of its newly-licensed eRapa in familial adenomatous polyposis scheduled for presentation at the 2024 Digestive Disease Week Annual Meeting.
    • Meta Materials Inc. (NASDAQ:MMAT) gained 64.4% to $3.78 after the company late Monday announced an update on its investigation into potential naked short selling, which began in June 2023.
    • FLJ Group Limited (NASDAQ:FLJ) jumped 60% to $1.2521.
    • AgriFORCE Growing Systems Ltd (NASDAQ:AGRI) shares climbed 41% to $0.1814 after jumping over 25% on Monday.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) climbed 38.2% to $5.25 after jumping around 9% on Monday. The company, last week, reported first-quarter financial results.
    • Complete Solaria, Inc. (NASDAQ:CSLR) gained 35.3% to $1.5828.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) surged 28% to $1.4813.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) rose 26% to $0.7801 following first-quarter results.
    • Xylo Technologies Ltd. (NASDAQ:XYLO) gained 21.3% to $2.3780. Xylo Technologies announced plans to acquire a leading AI technology company.
    • Ault Alliance, Inc. (NYSE:AULT) rose 18% to $0.4630 after the company reported a year-over-year increase in first-quarter financial results.
    • Lichen China Limited (NASDAQ:LICN) gained 15% to $1.77.
    • Waldencast plc (NASDAQ:WALD) gained 15% to $5.00 following first-quarter results.
    • Larimar Therapeutics, Inc.. (NASDAQ:LRMR) rose 12.3% to $8.16 after the company announced that the FDA removed the partial clinical hold previously placed on the nomlabofusp clinical program.
    • Transcat, Inc. (NASDAQ:TRNS) rose 10.1% to $136.63 following better-than-expected quarterly earnings.
    • XPeng Inc. (NYSE:XPEV) gained 10% to $9.12 after the company reported better-than-expected first-quarter results and issued second-quarter guidance.
    • Bloom Energy Corporation (NYSE:BE) rose 9.7% to $14.18.
    • Allogene Therapeutics, Inc. (NASDAQ:ALLO) gained 8.5% to $2.8090 after falling over 6% on Monday.

    Losers

    • Cheetah Net Supply Chain Service Inc. (NASDAQ:CTNT) fell 67% to $4.77 after jumping over 36% on Monday.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) shares fell 60.5% to $0.0623 after the company reported a year-over-year decrease in first-quarter financial results. Also, the company announced a registered direct offering.
    • LuxUrban Hotels Inc. (NASDAQ:LUXH) fell 42.4% to $0.2585 after the company announced the pricing of its public offering of 30.50 million common shares at $0.25 per share.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) dipped 33% to $0.1331.
    • American Oncology Network, Inc. (NASDAQ:AONC) fell 28.5% to $2.00. American Oncology Network announced voluntary delisting from the Nasdaq.
    • MultiMetaVerse Holdings Limited (NASDAQ:MMV) dipped 28% to $0.9497. MultiMetaVerse, on Monday, signed a term sheet to acquire Bowong Technology.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares fell 27.6% to $0.1371 after jumping 80% on Monday.
    • Rubicon Technologies, Inc. (NYSE:RBT) fell 27% to $0.2482 after the company reported a year-over-year decrease in first-quarter sales results.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) dipped 26.6% to $0.1160.
    • iSun, Inc. (NASDAQ:ISUN) shares fell 25.3% to $0.1250 after climbing around 15% on Monday.
    • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares fell 24.9% to $0.1310 following a 47% surge on Monday. The company last week announced it launched new Avenova product bundles aimed at providing tailored, cost-effective relief for dry eye symptoms.
    • Akanda Corp. (NASDAQ:AKAN) fell 24.4% to $0.1010.
    • Scorpius Holdings, Inc. (NYSE:SCPX) shares fell 24.3% to $0.2574. Scorpius shares jumped around 55% on Monday after the company announced expansion in San Antonio with a new storage and testing facility.
    • Rubicon Technologies, Inc. (NYSE:RBT) shares dipped 24.1% to $0.2582 in pre-market trading after the company reported a year-over-year decrease in first-quarter sales results.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 22% to $1.3950.
    • Daré Bioscience, Inc. (NASDAQ:DARE) tumbled 21.7% to $0.4775.
    • Peloton Interactive, Inc. (NASDAQ:PTON) fell 15.7% to $3.2950 after the company announced it will offer $275 million aggregate principal amount of convertible senior notes in a private offering.
    • Zenvia Inc. (NASDAQ:ZENV) shares fell 15.2% to $3.25 after jumping over 67% on Monday.
    • Gaotu Techedu Inc. (NYSE:GOTU) shares declined 13.4% to $7.09 following results for the first quarter.
    • Oddity Tech Ltd. (NASDAQ:ODD) fell 12.5% to $35.88 following a short seller report.
    • Hesai Group (NASDAQ:HSAI) shares declined 12.2% to $4.62 following first-quarter results.
    • Forward Air Corporation (NASDAQ:FWRD) fell 11.3% to $11.97 after announcing leadership transition.
    • Palo Alto Networks, Inc. (NASDAQ:PANW) fell 4.2% to $309.96. Palo Alto posted better-than-expected earnings for its third quarter. The company said it sees fourth-quarter adjusted earnings of $1.40 to $1.42 per share on total revenue of $2.15 billion to $2.17 billion.
    • Keysight Technologies, Inc. (NYSE:KEYS) fell 10.6% to $142.78. Keysight Technologies posted better-than-expected second-quarter earnings on Monday. The company said it expects third-quarter revenue of $1.18 billion to $1.20 billion and adjusted earnings of $1.30 to $1.36 per share.
    • Applied Digital Corporation (NASDAQ:APLD) dipped 10.4% to $4.10.
    • A10 Networks, Inc. (NYSE:ATEN) fell 8.2% to $15.10.
    • GameStop Corp. (NYSE:GME) declined 7.6% to $21.38.
    • Nordson Corporation (NASDAQ:NDSN) fell 7.5% to $248.28 following mixed second-quarter earnings and soft third-quarter revenue guidance.
    • Amer Sports, Inc. (NYSE:AS) fell 7.4% to $14.83 after the company reported first-quarter earnings.
    • JD.com, Inc. (NASDAQ:JD) shares declined 3.2% to $33.63 after the company reported interim first-quarter results and announced a proposed offering of $1.5 billion convertible senior notes.

    Now Read This: This Walt Disney Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

    Get the next $AGRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRI
    $AKAN
    $ALLO
    $AONC

    CompanyDatePrice TargetRatingAnalyst
    Hesai Group
    $HSAI
    3/26/2026Outperform
    BNP Paribas Exane
    XPeng Inc.
    $XPEV
    3/23/2026$19.00Outperform → Neutral
    Macquarie
    Palo Alto Networks Inc.
    $PANW
    3/3/2026$185.00Sell → Buy
    Arete
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$23.00Outperform → In-line
    Evercore ISI
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$16.00Overweight → Neutral
    Analyst
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$13.00Equal Weight → Underweight
    Barclays
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$10.00Buy → Underperform
    BofA Securities
    ODDITY Tech Ltd.
    $ODD
    2/25/2026Buy → Hold
    Needham
    More analyst ratings

    $AGRI
    $AKAN
    $ALLO
    $AONC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XACIATO issued to DARE BIOSCIENCE INC

    Submission status for DARE BIOSCIENCE INC's drug XACIATO (ORIG-1) with active ingredient CLINDAMYCIN PHOSPHATE has changed to 'Approval' on 12/07/2021. Application Category: NDA, Application Number: 215650, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/7/21 12:35:25 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BNP Paribas Exane initiated coverage on Hesai Group

    BNP Paribas Exane initiated coverage of Hesai Group with a rating of Outperform

    3/26/26 8:49:19 AM ET
    $HSAI
    Industrial Machinery/Components
    Industrials

    XPeng downgraded by Macquarie with a new price target

    Macquarie downgraded XPeng from Outperform to Neutral and set a new price target of $19.00

    3/23/26 8:28:29 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    Palo Alto Networks upgraded by Arete with a new price target

    Arete upgraded Palo Alto Networks from Sell to Buy and set a new price target of $185.00

    3/3/26 8:20:38 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 7:46:04 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hamilton Thomas Edward bought $500,000 worth of shares (100,000 units at $5.00), increasing direct ownership by 18% to 664,798 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:41 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Thomas Frank E bought $25,000 worth of shares (5,000 units at $5.00), increasing direct ownership by 250% to 7,000 units (SEC Form 4)

    4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)

    3/2/26 4:30:36 PM ET
    $LRMR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRI
    $AKAN
    $ALLO
    $AONC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GameStop Corporation

    SCHEDULE 13G/A - GameStop Corp. (0001326380) (Subject)

    3/26/26 6:39:53 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Forward Air Corporation

    SCHEDULE 13G/A - FORWARD AIR CORP (0000912728) (Subject)

    3/26/26 6:37:39 PM ET
    $FWRD
    Integrated Freight & Logistics
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Bloom Energy Corporation

    SCHEDULE 13G/A - Bloom Energy Corp (0001664703) (Subject)

    3/26/26 4:44:15 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bloom Energy Appoints Simon Edwards as Chief Financial Officer

    Bloom Energy (NYSE:BE), a global leader in onsite power solutions, today announced the appointment of Simon Edwards as Chief Financial Officer, effective April 13, 2026. A seasoned finance executive with nearly two decades of experience scaling technology companies, Edwards brings a rare combination of operational rigor, systems leadership, and deep exposure to digital infrastructure that aligns with Bloom's strength, market focus and strategy – to be a solution for power availability as it becomes the defining constraint on the AI industry and its growth. Edwards joins Bloom from AI-inference leader Groq, where he most recently served as CEO after initially joining as CFO. At Groq, he le

    3/26/26 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update

    Company Highlights Commercial Launch of DARE to PLAY™ Sildenafil Cream, Pipeline of Women's Health Solutions, and Multiple Near-Term Potential Catalysts Conference Call and Webcast Today at 4:30 p.m. ET SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today reported financial results for the year ended December 31, 2025, and provided a business update. "We are not a company that is just getting into women's health. We are a women's health biotech company – and we believe 2026 is the year investors wi

    3/26/26 4:01:00 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Onfolio Holdings Sets Full Year 2025 Earnings Call for April 1, 2026, at 8:00 a.m. ET

    WILMINGTON, Del., March 26, 2026 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (NASDAQ:ONFO, ONFOW)) (OTC:ONFOP) (the "Company" or "Onfolio"), an owner-operator of cash-generative online businesses, will hold a conference call on Wednesday, April 1, 2026, at 8:00 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. Onfolio's financial results will be reported in a press release prior to the conference call. The Company's management will host the conference call, followed by a live question and answer period. Date: Wednesday, April 1, 2026Time: 8:00 a.m. Eastern timeWebcast Link: HereDial-In Link: HereToll-free dial-in number: 1-877-704-4453Internation

    3/26/26 9:00:00 AM ET
    $ONFO
    EDP Services
    Technology

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Li Jeffrey K

    4 - Keysight Technologies, Inc. (0001601046) (Issuer)

    3/26/26 6:03:42 AM ET
    $KEYS
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Dhanasekaran Satish

    4 - Keysight Technologies, Inc. (0001601046) (Issuer)

    3/26/26 6:03:49 AM ET
    $KEYS
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Dougherty Neil

    4 - Keysight Technologies, Inc. (0001601046) (Issuer)

    3/26/26 6:03:55 AM ET
    $KEYS
    Industrial Machinery/Components
    Industrials

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Financials

    Live finance-specific insights

    View All

    Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update

    Company Highlights Commercial Launch of DARE to PLAY™ Sildenafil Cream, Pipeline of Women's Health Solutions, and Multiple Near-Term Potential Catalysts Conference Call and Webcast Today at 4:30 p.m. ET SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today reported financial results for the year ended December 31, 2025, and provided a business update. "We are not a company that is just getting into women's health. We are a women's health biotech company – and we believe 2026 is the year investors wi

    3/26/26 4:01:00 PM ET
    $DARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Onfolio Holdings Sets Full Year 2025 Earnings Call for April 1, 2026, at 8:00 a.m. ET

    WILMINGTON, Del., March 26, 2026 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (NASDAQ:ONFO, ONFOW)) (OTC:ONFOP) (the "Company" or "Onfolio"), an owner-operator of cash-generative online businesses, will hold a conference call on Wednesday, April 1, 2026, at 8:00 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. Onfolio's financial results will be reported in a press release prior to the conference call. The Company's management will host the conference call, followed by a live question and answer period. Date: Wednesday, April 1, 2026Time: 8:00 a.m. Eastern timeWebcast Link: HereDial-In Link: HereToll-free dial-in number: 1-877-704-4453Internation

    3/26/26 9:00:00 AM ET
    $ONFO
    EDP Services
    Technology

    GameStop Reports Fourth Quarter and Fiscal Year 2025 Results

    GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f

    3/24/26 4:02:00 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Leadership Updates

    Live Leadership Updates

    View All

    Bloom Energy Appoints Simon Edwards as Chief Financial Officer

    Bloom Energy (NYSE:BE), a global leader in onsite power solutions, today announced the appointment of Simon Edwards as Chief Financial Officer, effective April 13, 2026. A seasoned finance executive with nearly two decades of experience scaling technology companies, Edwards brings a rare combination of operational rigor, systems leadership, and deep exposure to digital infrastructure that aligns with Bloom's strength, market focus and strategy – to be a solution for power availability as it becomes the defining constraint on the AI industry and its growth. Edwards joins Bloom from AI-inference leader Groq, where he most recently served as CEO after initially joining as CFO. At Groq, he le

    3/26/26 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™

    NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), today announced a collaboration with ProMD Health as part of the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program. ProMD was selected for its strong multi-location network of 17 practices and its commitment to clinical excellence, making it an ideal evaluator to rigorously examine Obagi® saypha® MagIQ™ alongside comprehensive skincare protocols across its multi-state provider base. Through this collaboration, ProMD providers will participate in a structured evaluat

    3/19/26 8:29:00 AM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary

    Greenwave Announces Appointment of Chelsea Pullano as Chief Financial Officer

    Chesapeake, VA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that the board of directors ("Board") of the Company appointed Chelsea Pullano as Chief Financial Officer of the Company, effective February 5, 2026. Ms. Pullano's appointment is in connection with the Company's entry into the scope of work agreement with MACK Financial Solutions, LLC ("MACK"), dated January 2, 2026, pursuant to which MACK agreed to provide professional services to the Company, including oversight of all bookkeeping, financial reporting and SEC r

    2/10/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    $AGRI
    $AKAN
    $ALLO
    $AONC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Amer Sports Inc.

    SC 13D/A - Amer Sports, Inc. (0001988894) (Subject)

    12/12/24 7:02:15 PM ET
    $AS
    Apparel
    Consumer Discretionary